Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?

Journal of the European Academy of Dermatology and Venereology : JEADV
A LangenbruchM Augustin

Abstract

The Dermatology Life Quality Index (DLQI) is the most frequently used health-related quality of life (HRQoL) instrument for skin diseases. According to the DLQI instructions, the responses 'not relevant' and 'my skin problem has not at all affected this aspect of life' ('not at all') have to be scored as 0 = no HRQoL impairments. The aim of this study was to estimate potential bias of DLQI measurements for patients with psoriasis based on items considered to be not relevant. One thousand two hundred forty-three patients with psoriasis were surveyed in a cross-sectional study. Disease severity (Psoriasis Area and Severity Index, PASI) and subjective health state (EuroQoL Visual Analogue Scale, EQ VAS) were compared per DLQI item between patients who answered the respective question 'not relevant' and those who answered 'not at all'. Patients who declared a DLQI item to be not relevant showed a higher disease severity and a lower health state. Results indicate that patients who declare a DLQI item to be not relevant have a higher disease-related burden than those who do not feel affected by their psoriasis in the same aspect of life. If aspects of life are considered to be not relevant due to high disease burden, this should be r...Continue Reading

References

Jan 1, 1978·Dermatologica·T Fredriksson, U Pettersson
May 1, 1994·Clinical and Experimental Dermatology·A Y Finlay, G K Khan
Jun 6, 1996·Health Policy·R Brooks
Nov 7, 1999·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·M AugustinU Amon
Apr 16, 2004·The Journal of Investigative Dermatology. Symposium Proceedings·Victoria Lewis, Andrew Y Finlay
May 13, 2005·The British Journal of Dermatology·A Y Finlay
Sep 28, 2005·The Journal of Investigative Dermatology·Yan HongboAndrew Y Finlay
May 20, 2006·Acta Dermato-venereologica·Tamar NijstenStephen P McKenna
Oct 13, 2006·Health and Quality of Life Outcomes·UNKNOWN U.S. Department of Health and Human Services FDA Center for Drug Evaluation and ResearchUNKNOWN U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health
Sep 22, 2010·Archives of Dermatological Research·U MrowietzN Yawalkar
Sep 2, 2011·The Journal of Investigative Dermatology·James TwissStephen P McKenna
Jan 11, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·C A C PrinsenUNKNOWN EADV Taskforce on Quality of Life
Jan 24, 2015·Dermatology : International Journal for Clinical and Investigative Dermatology·M K A BasraA Y Finlay
May 22, 2016·Archives of Dermatological Research·Anna LangenbruchMatthias Augustin

❮ Previous
Next ❯

Citations

Mar 2, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·F RenczM Augustin
Jan 27, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·B ElewskiG Yosipovitch
Nov 12, 2019·The British Journal of Dermatology·A M Bashyam, S R Feldman
Apr 13, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·M AugustinC E M Griffiths
Feb 5, 2021·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·John S BarbieriJunko Takeshita
Mar 14, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·A LangenbruchM Augustin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.